搜索临床试验以:CPI-1189
总计2138个结果
-
The First Affiliated Hospital with Nanjing Medical...The Second Hospital of Hebei Medical University; The First Affiliated Hospital of Soochow University 和其他合作者完全的
-
GlaxoSmithKline完全的
-
Cornerstone Pharmaceuticals撤销
-
Black Diamond Therapeutics, Inc.终止
-
Universidade do PortoLudwig-Maximilians - University of Munich; Fundação para a Ciência e a Tecnologia; Arcada University... 和其他合作者招聘中
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Center for Social Innovation, MassachusettsColumbia University; Hunter College of City University of New York完全的
-
FDA Office of Orphan Products DevelopmentSciClone Pharmaceuticals完全的
-
Karolinska InstitutetThe Swedish Research Council; Swedish Heart Lung Foundation; SOS Alarm招聘中
-
Columbia UniversityNational Institute of Mental Health (NIMH)完全的
-
Beta Pharma Shanghai完全的
-
AbbVie终止囊性纤维化 (CF)美国, 澳大利亚, 比利时, 匈牙利, 荷兰, 新西兰, 斯洛伐克, 英国
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的晚期成人原发性肝癌 | 局部不可切除的成人原发性肝癌 | 复发性成人原发性肝癌 | 复发性肝外胆管癌 | 不可切除的肝外胆管癌 | 肝外胆管胆管癌 | 胆囊胆管癌 | 成人原发性胆管细胞癌 | 转移性肝外胆管癌美国
-
VA Pacific Islands Health Care SystemU.S. Army Medical Research and Development Command完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Celon Pharma SANational Center for Research and Development, Poland完全的
-
Betta Pharmaceuticals Co., Ltd.尚未招聘
-
French Innovative Leukemia OrganisationAcute Leukemia French Association; French Intergroup of Myeloproliferative syndromes招聘中
-
Case Comprehensive Cancer Center主动,不招人
-
University of IowaNational Cancer Institute (NCI); Mayo Clinic; Pfizer完全的
-
Stanford UniversityNational Institutes of Health (NIH)撤销
-
Fusion Pharmaceuticals Inc.终止乳腺癌 | 胃癌 | 大肠癌 | 卵巢癌 | 肺癌 | 晚期实体瘤 | 头颈部鳞状细胞癌 | 肝癌 | 膀胱癌 | 易感 FGFR3 基因改变 | FGFR3 | FGFR3 过表达 | FGFR3受体 | FGFR3 蛋白过表达美国, 澳大利亚